These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 9635570)
21. Methylation analysis of the promoter F of estrogen receptor alpha gene: effects on the level of transcription on human osteoblastic cells. Penolazzi L; Lambertini E; Giordano S; Sollazzo V; Traina G; del Senno L; Piva R J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):1-9. PubMed ID: 15261302 [TBL] [Abstract][Full Text] [Related]
22. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. Kang GH; Lee S; Lee HJ; Hwang KS J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506 [TBL] [Abstract][Full Text] [Related]
23. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594 [TBL] [Abstract][Full Text] [Related]
24. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q. Bello MJ; Amiñoso C; Lopez-Marin I; Arjona D; Gonzalez-Gomez P; Alonso ME; Lomas J; de Campos JM; Kusak ME; Vaquero J; Isla A; Gutierrez M; Sarasa JL; Rey JA Acta Neuropathol; 2004 Nov; 108(5):413-21. PubMed ID: 15365725 [TBL] [Abstract][Full Text] [Related]
26. GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas. Rønneberg JA; Tost J; Solvang HK; Alnaes GI; Johansen FE; Brendeford EM; Yakhini Z; Gut IG; Lønning PE; Børresen-Dale AL; Gabrielsen OS; Kristensen VN Cancer Res; 2008 Jul; 68(14):5562-71. PubMed ID: 18632608 [TBL] [Abstract][Full Text] [Related]
27. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors. Toyota M; Shen L; Ohe-Toyota M; Hamilton SR; Sinicrope FA; Issa JP Cancer Res; 2000 Aug; 60(15):4044-8. PubMed ID: 10945606 [TBL] [Abstract][Full Text] [Related]
28. The relationship between gene-specific DNA methylation in leukocytes and normal colorectal mucosa in subjects with and without colorectal tumors. Ally MS; Al-Ghnaniem R; Pufulete M Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):922-8. PubMed ID: 19258481 [TBL] [Abstract][Full Text] [Related]
29. Microarray-based survey of CpG islands identifies concurrent hyper- and hypomethylation patterns in tissues derived from patients with breast cancer. Piotrowski A; Benetkiewicz M; Menzel U; Díaz de Ståhl T; Mantripragada K; Grigelionis G; Buckley PG; Jankowski M; Hoffman J; Bała D; Srutek E; Laskowski R; Zegarski W; Dumanski JP Genes Chromosomes Cancer; 2006 Jul; 45(7):656-67. PubMed ID: 16575877 [TBL] [Abstract][Full Text] [Related]
30. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Ottaviano YL; Issa JP; Parl FF; Smith HS; Baylin SB; Davidson NE Cancer Res; 1994 May; 54(10):2552-5. PubMed ID: 8168078 [TBL] [Abstract][Full Text] [Related]
31. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. Jarrard DF; Kinoshita H; Shi Y; Sandefur C; Hoff D; Meisner LF; Chang C; Herman JG; Isaacs WB; Nassif N Cancer Res; 1998 Dec; 58(23):5310-4. PubMed ID: 9850055 [TBL] [Abstract][Full Text] [Related]
32. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer. Sasaki M; Dharia A; Oh BR; Tanaka Y; Fujimoto S; Dahiya R Cancer Res; 2001 Jan; 61(1):97-102. PubMed ID: 11196205 [TBL] [Abstract][Full Text] [Related]
33. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090 [TBL] [Abstract][Full Text] [Related]
34. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma. Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139 [TBL] [Abstract][Full Text] [Related]
35. INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis. Hui R; Macmillan RD; Kenny FS; Musgrove EA; Blamey RW; Nicholson RI; Robertson JF; Sutherland RL Clin Cancer Res; 2000 Jul; 6(7):2777-87. PubMed ID: 10914724 [TBL] [Abstract][Full Text] [Related]
36. Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. Huang TH; Laux DE; Hamlin BC; Tran P; Tran H; Lubahn DB Cancer Res; 1997 Mar; 57(6):1030-4. PubMed ID: 9067264 [TBL] [Abstract][Full Text] [Related]
37. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene. Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589 [TBL] [Abstract][Full Text] [Related]
38. Examination of the DNA methylation properties in nontumorigenic and tumorigenic breast epithelial cell lines. Pilat MJ; Schwab ED; Yao KL; Pienta KJ Anticancer Res; 1998; 18(4A):2575-82. PubMed ID: 9703912 [TBL] [Abstract][Full Text] [Related]
39. Methylation of the human telomerase gene CpG island. Dessain SK; Yu H; Reddel RR; Beijersbergen RL; Weinberg RA Cancer Res; 2000 Feb; 60(3):537-41. PubMed ID: 10676632 [TBL] [Abstract][Full Text] [Related]
40. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers. Chen ST; Lin SY; Yeh KT; Kuo SJ; Chan WL; Chu YP; Chang JG Int J Mol Med; 2004 Oct; 14(4):577-82. PubMed ID: 15375584 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]